Cystoid oedema of macula is the most frequent problem following non-complicated cataract surgery, which leads to weakening of visual acutity. We have studied the treatment outcomes of the topical therapy with corticosteroids and nonsteroid antirheumatics during prospective randomized study in comparison with orally applied acethazolamide. However, 8 weeks later in treatment was observed a positive effect in both groups, on the eyes of patients, treated with acetazolamide, resorption of the oedema was faster, more intensive and ultimate visual acutity was statistically significantly better. Results demonstrated a benefit of combined therapy with antiinflamative drugs and orally prescribed acetazolamide in pseudophakic macular oedema
Background: To evaluate the clinical course of pseudophakic cystoid macular edema (PCME) treated wit...
ABSTRACT Pseudophakic cystoid macular edema (PCME) is a common complication following cataract surge...
Background: Define the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added...
Cystoid oedema of macula is the most frequent problem following non-complicated cataract surgery, wh...
Cystoid macular edema is a common cause for unexplained painless vision loss after cataract surgery....
Despite advances in cataract surgery, cystoid macular edema (CME) is one of the most common causes o...
Pseudophakic cystoid macular edema (CME) is a common complication following cataract surgery. Acute ...
A 69 years old women underwent uneventful cataract surgery of her left eye with phacoemulsification ...
The purpose of this review was to determine the optimum pharmacologic treatment for cystoid macular ...
Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leadi...
Background: the purpose of this study is to assess the effectiveness of topical nonsteroidal anti-in...
Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leadi...
Cataracts are the leading cause of treatable blindness world-wide. Surgically removing a symptomatic...
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Ne...
Twenty-five eyes (23 patients) with inflammatory cystoid macular edema (CME) (11 after cataract surg...
Background: To evaluate the clinical course of pseudophakic cystoid macular edema (PCME) treated wit...
ABSTRACT Pseudophakic cystoid macular edema (PCME) is a common complication following cataract surge...
Background: Define the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added...
Cystoid oedema of macula is the most frequent problem following non-complicated cataract surgery, wh...
Cystoid macular edema is a common cause for unexplained painless vision loss after cataract surgery....
Despite advances in cataract surgery, cystoid macular edema (CME) is one of the most common causes o...
Pseudophakic cystoid macular edema (CME) is a common complication following cataract surgery. Acute ...
A 69 years old women underwent uneventful cataract surgery of her left eye with phacoemulsification ...
The purpose of this review was to determine the optimum pharmacologic treatment for cystoid macular ...
Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leadi...
Background: the purpose of this study is to assess the effectiveness of topical nonsteroidal anti-in...
Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leadi...
Cataracts are the leading cause of treatable blindness world-wide. Surgically removing a symptomatic...
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Ne...
Twenty-five eyes (23 patients) with inflammatory cystoid macular edema (CME) (11 after cataract surg...
Background: To evaluate the clinical course of pseudophakic cystoid macular edema (PCME) treated wit...
ABSTRACT Pseudophakic cystoid macular edema (PCME) is a common complication following cataract surge...
Background: Define the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added...